Top Qs
Timeline
Chat
Perspective

DME (drug)

Pharmaceutical compound From Wikipedia, the free encyclopedia

DME (drug)
Remove ads

DME, also known as 3,4-dimethoxy-β-hydroxyphenethylamine or as β-hydroxy-3,4-DMPEA, is a psychoactive drug of the phenethylamine and BOx families.[1] It is the β-hydroxy derivative of 3,4-dimethoxyphenethylamine (3,4-DMPEA or DMPEA), which is an analogue of mescaline (3,4,5-TMPEA or TMPEA).[1]

Quick facts Clinical data, Other names ...
Remove ads

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists DME's dose as greater than 115 mg orally and its duration as unknown.[1] At a dose of 115 mg orally, its effects included faint nausea and possible alertness, but described as "substantially no effects".[1]

Chemistry

Synthesis

The chemical synthesis of DME has been described.[1]

Analogues

Analogues of DME (β-hydroxy-3,4-DMPEA) include BOH (β-methoxy-MDPEA) and BOM (β-methoxymescaline; β-methoxy-3,4,5-TMPEA), among others.[1]

History

DME was first described in the scientific literature by Alexander Shulgin and colleagues in 1969.[2] It was subsequently described in greater detail by Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).[1]

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[3]

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads